| Temple Morris, LCSW-C | |
|
4405 E West Hwy, Bethesda, MD 20814-4522 | |
| (301) 706-9924 | |
| Not Available |
| Full Name | Temple Morris |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4405 E West Hwy, Bethesda, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134775802 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Temple Morris, LCSW-C 4405 E West Hwy, Bethesda, MD 20814-4522 Ph: () - | Temple Morris, LCSW-C 4405 E West Hwy, Bethesda, MD 20814-4522 Ph: (301) 706-9924 |
News Archive
Speaking at the ONE campaign and (RED)'s "Beginning of the End of AIDS" event at George Washington University in Washington, D.C., to mark World AIDS Day on Thursday, "President Obama ... announced a deepened U.S. commitment to fighting the pandemic, declaring 'make no mistake, we are going to win this fight,'" ABC News reports (Bruce, 12/1).
Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has released its official and final report regarding the agency's review of allegations made in a July newspaper article concerning the company's Morgantown, W.Va., manufacturing facility.
BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, has released findings from the second wave of its LaunchTrends® Yervoy and Zelboraf report, in which 103 U.S.-based medical oncologists were surveyed about their current and expected treatment patterns in advanced melanoma.
Placing a stent in a key artery in the neck is safer than ever in patients ineligible for the standard surgical treatment of carotid artery disease, according to a new study published online today in the Journal of Vascular Surgery.
A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA plus prednisone compared to patients treated with prednisone plus placebo.
› Verified 4 days ago
Ms. Annette Jolles, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7420 Westlake Ter, Apt 1202, Bethesda, MD 20817 Phone: 301-469-9202 | |
Michelle Christine Herman Brueser, LCSW, LICSW, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7990 Old Georgetown Rd # 10b, Bethesda, MD 20814 Phone: 919-442-8556 | |
Elizabeth Draddy Vangaever, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4977 Battery Ln, Bethesda, MD 20814 Phone: 301-675-7086 | |
Nicole O'connor, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 9080 Beale Rd, Bethesda, MD 20889 Phone: 800-526-7101 | |
Ms. Judith R. Peres, LCSW-C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4405 E West Hwy, Suite 411, Bethesda, MD 20814 Phone: 301-455-5140 | |
Mrs. Georgia Chipouras Munson, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6040 Southport Dr, Bethesda, MD 20814 Phone: 301-493-4200 Fax: 301-493-6209 | |
Ms. Anne Weiss, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6410 Rockledge Drive, Suite 308, Bethesda, MD 20817 Phone: 301-245-2601 |